Holen Sie sich die Stockscreener-App
0.4661
10.57%
0.0446
Handel nachbörslich:
.46
-0.00605
-1.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.4215
Offen:
$0.43
24-Stunden-Volumen:
975.03K
Relative Volume:
0.46
Marktkapitalisierung:
$19.36M
Einnahmen:
$62.71M
Nettoeinkommen (Verlust:
$-10.48M
KGV:
-0.7398
EPS:
-0.63
Netto-Cashflow:
$-13.77M
1W Leistung:
+27.58%
1M Leistung:
+33.54%
6M Leistung:
-13.69%
1J Leistung:
-84.62%
1-Tages-Spanne:
$0.421
$0.4785
1-Wochen-Bereich:
$0.371
$0.4785
52-Wochen-Spanne:
$0.2179
$3.3654
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
(215) 345-0919
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Vergleichen Sie PRPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.4661 | 17.51M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.18 | 33.94B | 6.63B | 1.17B | 1.19B | 4.05 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
What analysts say about ProPhase Labs Inc. stockDynamic investment growth - PrintWeekIndia
Prophase Labs Holds Annual Stockholders Meeting - TipRanks
ProPhase Labs Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional
How ProPhase Labs Inc. stock reacts to Fed policy changesTremendous growth opportunities - jammulinksnews.com
Is ProPhase Labs Inc. a good long term investmentFree Wealth Planning Blueprint - PrintWeekIndia
ProPhase Labs shares rise 1.15% premarket after closing $3 million senior secured convertible notes financing. - AInvest
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewswire
ProPhase Labs secures $3 million in convertible notes financing By Investing.com - Investing.com Nigeria
ProPhase Labs secures $3 million in convertible notes financing - Investing.com Australia
Prophase Labs Secures $3 Million in Private Financing - TipRanks
ProPhase Labs Raises $3M as Bridge to $50M Covid Collections and Crypto Strategy Launch - Stock Titan
What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com
ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire
Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks
ProPhase Labs explores reverse merger with digital asset company - Investing.com
ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail
ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan
What makes ProPhase Labs Inc. stock price move sharplyHigh Potential Safe Trades - beatles.ru
Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest
Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest
How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail
PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan
Prophase Labs Secures $1M in New Loan Agreements - TipRanks
ProPhase Labs, Inc. Receives Additional 180 Day Extension from N - GuruFocus
ProPhase Labs Inc. Receives 180-Day Extension from Nasdaq to Regain Bid Price Compliance - Quiver Quantitative
ProPhase Labs, Inc. Receives Additional 180 Day Extension - GlobeNewswire
ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener
Prophase Labs Appoints Carolina Abenante as Director - TipRanks
ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.50%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):